Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colonic Neoplasms 10Stomach Neoplasms 3Rectal Neoplasms 3Carcinoma, Hepatocellular 3Neoplastic Cells, Circulating 2Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Ulcer 1Prostatic Neoplasms 1Polyps 1Patient Satisfaction 1Pancreatic Neoplasms 1Pain, Postoperative 1Overweight 1Ovarian Neoplasms 1Obesity 1Melanoma 1Hypoxia 1Esophageal Neoplasms 1Endobronchial Metastases 1Emergence Delirium 1Diverticulosis, Colonic 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

remimazolam 1Sugammadex 1Rocuronium 1Remifentanil 1Propofol 1Oxycodone 1Flumazenil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endobronchial Metastases × Propofol × Gastrointestinal × Clear all
NCT05468671 2022-10-26

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Zhejiang Cancer Hospital

Phase 4 Completed
34 enrolled
GastrointestinalThoracic

Endobronchial Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡